BCL2 and cervical cancer: As a result, since the increase in caspase‐3 and 9 activities and the Bax/Bcl‐2 ratio is considered an apoptotic marker (Klimentova et al. 2021), it was concluded that CHD has significant importance in cervical cancer research as a cytotoxic and apoptotic effective extract with its low IC50 value.